Search results
A Lesson From History: AI Is Not Likely To Kill Jobs
Forbes· 4 days agoAI adoption in businesses is beginning to grow. According to McKinsey’s State of AI in Early 2024 survey, which was released last week, nearly three quarters of U.S. businesses are now using ...
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
Benzinga· 5 days agoEMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival ...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
Morningstar· 3 days agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus intravenous infusion, resulted in a relatively ...
After the Valley View tornado, it’s community over profits for local eateries
Dallas Morning News· 6 days agoOnly 15 minutes from where an EF2 tornado with speeds of 135 mph destroyed a Shell gas station and...
Nancy Wynell Couch | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 5 days agoTwenty-something Nancy Couch was working at Texas Art Supply one day when business was slow. She was supposed to be in the stock room, but something...
Burkina Faso named most neglected crisis for second year in a row
KOAM· 3 days agoNine out of the 10 most neglected crises outlined in the report were in Africa, with Cameroon, Central African Republic, Mali, and Niger holding the second to fifth positions respectively. The ...
Little fish, big comeback: Endangered pupfish in Death Valley featured on television
Las Vegas Sun· 4 days agoThe hosts of “Wild Kingdom: Protecting the Wild,” Rae Wynn-Grant and Peter Gros, bring collected...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 2 days agoMitsubishi Tanabe Pharma America to Highlight Expansive ALS Research at the European Network to Cure ALS (ENCALS) 2024 Meeting PR Newswire JERSEY CITY, N.J., June 5, 2024 Data will be presented from eight abstracts spanning preclinical to real-world
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Forrest City Times-Herald· 3 days agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval of CARVYKTI®, the ...
Nudging Yourself Into Success in the Job Search | Herald Democrat
The Herald Democrat· 5 days agoFor more about this topic, be sure to check out the book Nudge by Richard H. Thaler and Cass R. Sunstein. First of all, it’s important to realize that even if you have good intentions, you might ...
